-
Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
-
Young Sup Woo, Joo Eon Park, Do-Hoon Kim, Inki Sohn, Tae-Yeon Hwang, Young-Min Park, Duk-In Jon, Jong-Hyun Jeong, Won-Myong Bahk
-
Psychiatry Investig. 2016;13(4):458-467. Published online July 25, 2016
-
-
Full text
PubReader
PDF
-
A Meta-Analysis Comparing Open-Label versus Placebo-Controlled Clinical Trials for Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: Lessons and Promises
-
Chi-Un Pae, Ho-Jun Seo, Boung Chul Lee, Jeong-Ho Seok, Hong Jin Jeon, Jong-Woo Paik, Kyung-Phil Kwak, Byung-Joo Ham, Changsu Han, Soo-Jung Lee
-
Psychiatry Investig. 2014;11(4):371-379. Published online October 20, 2014
-
-
Full text
PubReader
PDF